Evidence map›Paper›PMID 37581042›Full record

ArticleQuantitative imaging in medicine and surgery2023

Effective clinical response of lung adenocarcinoma harboring

Yanyan Wang, Chenchen Jiang, Mingyue Tang, Huiyuan Li, Cancan Zhao, Menglin Zhao, Yue Zhang, Xinwei Li, Jiaqi Mi, Honghong Shen and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Yanyan Wang *Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Chenchen Jiang *Cancer Neurobiology Group, School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia.
Mingyue TangDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Huiyuan LiDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Cancan ZhaoDepartment of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Menglin ZhaoDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Yue ZhangDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Xinwei LiDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Jiaqi MiDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Honghong ShenDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Zishu WangDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Fang SuDepartment of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
First Affiliated Hospital of Bengbu Medical College · CNUniversity of Newcastle Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37581042
PMCPMC10423355
OpenAlexW4382237167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.